Market Cap: $14.09M
CC
Cytosorbents Corporation
CTSO
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $14.09M
CytoSorbents Advances Blood Purification Solutions Amid Regulatory Anticipation CytoSorbents Corporation, a leader in blood purification technologies for critical care and cardiac surgery, prepares fo…
CytoSorbents Advances Blood Purification Technologies at Upcoming Healthcare Conference CytoSorbents Corporation, a leader in the field of blood purification, prepares to showcase its innovative solut…
CytoSorbents Advances Blood Purification Technologies in Critical Care CytoSorbents Corporation, a leader in blood purification technologies, is poised to showcase its innovations at the upcoming Jeff…
Cytosorbents Expands its Clinical Applications for Critical Care Cytosorbents, a leader in the development of innovative blood purification technologies, is advancing its clinical applications in crit…
Cytosorbents Focuses on Innovative Therapeutics to Address Critical Care Needs Cytosorbents is at the forefront of developing novel therapeutic solutions aimed at improving patient outcomes in critica…
Cytosorbents Advances Regulatory Strategy for DrugSorb™-ATR Device Cytosorbents Corporation continues to make significant strides in the development of its innovative DrugSorb™-ATR device. On Septembe…
Cytosorbents Hosts Global Webinar on Sepsis Treatment Innovations Cytosorbents Corporation, a pioneer in blood purification therapies designed for critical care and cardiac surgery, prepares to host a…
Cytosorbents Launches Educational Initiative on Sepsis Treatment Cytosorbents Corporation, a prominent player in blood purification therapies, announces an upcoming global webinar focused on the criti…
CytoSorbents Advances in Blood Purification Technologies Amid Industry Demand CytoSorbents Corporation, a leader in the field of blood purification for critical care and cardiac surgery, highlights it…
Cytosorbents Advances DrugSorb-ATR Amid FDA Review Process CytoSorbents Corporation, a key player in blood purification technologies, provides an important update regarding its DrugSorb™-ATR device, a…
CytoSorbents' Market Position: Analysts Offer Mixed Perspectives In the past three months, CytoSorbents Corporation (CTSO) has garnered attention from six analysts who have provided ratings reflecting…
Cytosorbents Faces Mixed Analyst Sentiment Amid Industry Challenges In recent weeks, CytoSorbents Corporation (CTSO) finds itself at a crossroads, as analysts present a spectrum of evaluations regardi…